Personal profile
Fingerprint
Dive into the research topics where Seung Tae Kim is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Angiogenesis gene signatures in patient-derived tumor spheroids for genetic and tumor angiogenesis profiling
Hyung, S., Ko, J., An, M., Kim, S. T., Park, S. H., Hong, J. Y., Lim, S. H., Kim, K. M. & Lee, J., 24 Sep 2025, In: Journal of Materials Chemistry B. 13, 37, p. 11597-11610 14 p.Research output: Contribution to journal › Article › peer-review
-
Changes in Cancer Care for Patients Aged 80 and Above: A Cohort Study from Samsung Comprehensive Cancer Center in South Korea
Kim, S. T., Kang, D., Kim, S. J., Lee, J. H., Kim, H. K., Cho, Y. B., Paik, Y. H., Kim, S. W., Jeong, B. C., Seol, H. J., Chung, M. K., Lee, K. T., Kim, K., Seo, S. W., Lee, J. W., Park, H. C., Shin, D. W., Cho, J., Kim, W. & Lee, J. & 1 others, , Jun 2025, In: Cancers. 17, 12, 2017.Research output: Contribution to journal › Article › peer-review
Open Access -
Comprehensive analysis of KRAS aberrations in pan-cancer, with a focus on prognostic and therapeutic implications
Jung, J., Hong, J. Y., Park, S. H., Park, J. O., Park, Y. S., Lim, H. Y., Kang, W. K., Lee, J., Ha, S. Y., Ahn, S., Lim, S. H. & Kim, S. T., 1 Jan 2025, In: Therapeutic Advances in Medical Oncology. 17Research output: Contribution to journal › Article › peer-review
Open Access1 Link opens in a new tab Scopus citations -
Comprehensive molecular characterization to predict immunotherapy response in advanced biliary tract cancer: a phase II trial of pembrolizumab
Kim, R., Park, J. K., Kwon, M., An, M., Hong, J. Y., Park, J. O., Lim, S. H. & Kim, S. T., 2025, In: Oncology Research. 33, 1, p. 57-65 9 p.Research output: Contribution to journal › Article › peer-review
Open Access5 Link opens in a new tab Scopus citations -
Determinants of Response to Sequential Pembrolizumab with Trastuzumab plus Platinum/5-FU in HER2-Positive Gastric Cancer: A Phase II Chemoimmunotherapy Trial
Lim, S. H., An, M., Lee, H., Heo, Y. J., Min, B. H., Mehta, A., Wright, S., Kim, K. M., Kim, S. T., Klempner, S. J. & Lee, J., 15 Apr 2025, In: Clinical Cancer Research. 31, 8, p. 1476-1490 15 p.Research output: Contribution to journal › Article › peer-review
Open Access7 Link opens in a new tab Scopus citations